## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%); PEG 6.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($421.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 8)

**1. Synopsys, Inc. Notice of Application Deadline for Recovery**
- Source: GlobeNewswire | 20251217T040934 | Bearish | Relevance: 100%
- Kahn Swick & Foti, LLC (KSF) has notified investors in Synopsys, Inc. (NasdaqGS: SNPS) of a class action securities lawsuit. The lawsuit seeks to recover losses for investors affected by alleged securities fraud between December 4, 2024, and September 9, 2025, or those who acquired Synopsys common stock through the Ansys acquisition. Investors who suffered losses have until December 30, 2025, to request appointment as lead plaintiff.

**2. Levi & Korsinsky Urges Synopsys, Inc. (SNPS) Shareholders to Act Before Lead Plaintiff Deadline December 30, 2025**
- Source: WANE 15 | 20251216T210824 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has announced that a securities class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made false statements regarding its Design IP business and the impact of increased focus on AI customers. Shareholders who suffered losses are urged to contact Levi & Korsinsky before the lead plaintiff deadline of December 30, 2025, to explore their rights.

**3. Synopsys (SNPS) Stock News Today (Dec. 16, 2025): Fresh Analyst Forecasts, JPMorgan “Top Picks” Call, and What Q4 Results Signal for 2026**
- Source: ts2.tech | 20251216T200843 | Somewhat-Bullish | Relevance: 100%
- Synopsys (SNPS) stock is experiencing renewed investor focus due to new Wall Street price-target updates, a "top picks" designation from JPMorgan, and legal notices regarding a class action lawsuit. Investors are balancing the post-earnings reset, including the Ansys acquisition and IP business performance, against strategic tailwinds like AI infrastructure demand and a deepened partnership with Nvidia. Analyst forecasts are generally constructive, with consensus price targets clustering in the mid-$500s, reflecting both optimism about Synopsys' strategic positioning and caution regarding IP growth, geopolitical risks, and integration execution.

**4. Investors in Synopsys, Inc. Should Contact Levi & Korsinsky Before December 30, 2025 to Discuss Your Rights - SNPS**
- Source: Morningstar | 20251216T140933 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP advises investors in Synopsys, Inc. (NASDAQ: SNPS) of a class action securities lawsuit. The lawsuit alleges that Synopsys made false statements and/or concealed issues regarding the deteriorating economics of its Design IP business due to an increased focus on AI customers, which negatively impacted financial results. Investors who suffered losses between December 4, 2024, and September 9, 2025, have until December 30, 2025, to request to be appointed lead plaintiff.

**5. Recover Investment Losses: Class Action Initiated Against Synopsys, Inc. (SNPS)**
- Source: WHNT.com | 20251216T120835 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a securities class action lawsuit against Synopsys, Inc. (SNPS) on behalf of investors who suffered losses between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made false statements and concealed the negative impact of its focus on AI customers on its Design IP business, which deteriorated financial results. Investors are encouraged to contact Levi & Korsinsky to explore potential recovery options.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.54M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Valuation stretched: PEG 6.3x requires aggressive growth execution.
2. Long-term trend broken: trading 7.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 6.26 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Insider buying signal ($0.5M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $86.3B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.26 |
| Forward P/E | 26.8 |
| Current P/E | 31.5 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.6% to 0.5% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Below SMA200 (0.93x), long-term trend not supportive. MACD histogram positive (1.91), confirming momentum. RSI neutral at 54. OFD pattern: -FTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.49% (CS: 31) | Neutral |
| RSI_14 | 54.4 | Neutral |
| MACD Histogram | 1.91 | Bullish |
| vs SMA20 | 1.031x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 0.928x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $453.07
- **Stop Loss:** $421.21 (7.0% risk)
- **Target:** $484.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 14
- **Position Value:** $6,342.98
- **Portfolio %:** 6.34%
- **Risk Dollars:** $450.00
- **Risk Per Trade:** 0.45%
- **Modifiers:** L1 90% | L2 50% | Combined 0.45x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_OFF (HIGH) | 0.90x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*RISK_OFF regime with deteriorating conditions. VIX rising to 17.6 (+11.7% over 5 days) signals increasing anxiety, while narrow breadth at 52.6% indicates selective participation. AI infrastructure cost concerns are pressuring tech leadership, creating sector rotation challenges in a late-cycle environment.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-07 01:40 | MRS_10*